Example: bankruptcy

CMS Manual System

3. Changes for COVID-19 Monoclonal Antibody Therapy Product and Administration Codes . a. New COVID-19 Monoclonal Antibody Therapy and Administration codes for Sotrovimab. On May 26, 2021, the Food and Drug Administration (FDA) released an Emergency Use Authorization (EUA) for Sotrovimab, a COVID-19 monoclonal antibody product.

Tags:

  Monoclonal

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries